Reynders McVeigh Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
|
|||||
2021
Q4 | $299K | Buy |
|
|||||
2020
Q4 | – | Sell |
|
|||||
2020
Q3 | $263K | Sell |
|
|||||
2020
Q2 | $644K | Buy |
|
|||||
2018
Q1 | – | Sell |
|
|||||
2017
Q4 | $309K | Sell |
|
|||||
2017
Q3 | $506K | Sell |
|
|||||
2017
Q2 | $554K | Buy |
|
|||||
2017
Q1 | $540K | Sell |
|
|||||
2016
Q4 | $501K | Sell |
|
|||||
2016
Q3 | $636K | Sell |
|
|||||
2016
Q2 | $688K | Sell |
|
|||||
2016
Q1 | $773K | Sell |
|
|||||
2015
Q4 | $866K | Sell |
|
|||||
2015
Q3 | $1.01M | Sell |
|
|||||
2015
Q2 | $1.33M | Sell |
|
|||||
2015
Q1 | $1.95M | Sell |
|
|||||
2014
Q4 | $3.32M | Sell |
|
|||||
2014
Q3 | $13.6M | Buy |
|
|||||
2014
Q2 | $13M | Buy |
|
|||||
2014
Q1 | $13M | Buy |
|
|||||
2013
Q4 | $12.5M | Buy |
|
|||||
2013
Q3 | $11.3M | Buy |
|
|||||
2013
Q2 | $10.6M | Buy |
|